|
|
原帖由 goodoctor 於 2006-12-10 22:42 發表
同意. 新鮮人總是這樣, 找一些貼子, 似乎是用來支持他/她自己觀點的. 當你和他
/她討論這些文章的時候, 他/她感覺能辯下去, 就和你胡攪蠻纏下去; 如果感覺不
行, 就會說, 貼子不是他/她的, 找作者去.
...
請看清楚這是現代科學還是稀奇古怪, 荒謬無比, 和現代醫學明顯相抵觸的文章, 當然貼子是我貼的, 但文責顯然是作者本人的, 為什麼文章的作者中要寫一個人名對此文負責? 這叫版權. 也就是知識產權. 我沒有權利代作者回答問題. 你好像從來沒有寫過論文, 居然對此毫無所知.
http://www.ncbi.nlm.nih.gov/entr ... p;list_uids=9303280
: Drugs Aging. 1997 Sep;11(3):206-28. Links
Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.Newhouse PA, Potter A, Levin ED.
Department of Psychiatry, University of Vermont College of Medicine, Burlington, USA.
Advances in our understanding of the structure, function and distribution of nicotinic acetylcholine receptors in the CNS have provided the impetus for new studies examining the role(s) that these receptors and associated processes may play in CNS functions. Further motivation has come from the realisation that such receptors must be involved in the maintenance of cigarette smoking, and from clues provided by studies of degenerative neurological diseases such as Alzheimer's disease and Parkinson's disease, in which the loss of nicotinic receptors has been described. Ongoing investigations of the molecular substructure of central nicotinic receptors and their pharmacology have begun to open up new possibilities for novel CNS therapeutics with nicotinic agents. Exploiting these possibilities will require understanding of the role(s) that these receptor systems play in human cognitive, behavioural, motor and sensory functioning. Clues from careful studies of human cognition are beginning to emerge and will provide direction for studies of potentially therapeutic novel nicotinic agents. Despite the promising results of acute studies, few long term studies with nicotine or nicotinic drugs have been performed in dementing disorders. Thus there is uncertainty as to whether long term nicotinic treatment will provide sustained cognitive benefit. It is even more uncertain whether such cognitive benefit will have a significant clinical impact on patients and their families. To maximise the potential benefit of long term treatment with nicotinic agonists (or other cholinergic drugs), we suggest that drug treatment should be combined with cognitive rehabilitation strategies. This will enable patients and/or their families to focus on the particular cognitive domains that may be improved.
還要更多的文章嗎? 這篇文摘可是來自NIH 圖書館.
[ 本帖最後由 新鮮人 於 2006-12-11 12:01 編輯 ] |
|
樓主: sujie_alex
狗仔卡
新鮮人說他不是內科醫生也不是家庭醫生(全科醫生)而是個專科醫生， 我倒認為新鮮人是個「全科醫生」---- 中醫全科。新鮮人的中醫知識遠遠高於他的西醫專科。新鮮人說「老年人戒煙可能引起Parkinson&qu ... 
